Traders had been covering shorts ahead of the ruling released Friday, but are re-establishing their positions. » Read More
Billionaire investor Carl Icahn joined CNBC's "Squawk Box" on Thursday to share his investment outlook and stock strategy.
The billionaire investor says he still thinks very highly of Apple, but remains concerned about its prospects in China.
"I don't think anybody who supports Donald is happy" with Trump's comment about a Mexican-American judge, Icahn told CNBC.
Carl Icahn says bearish bets by George Soros have some merit because the stock market has been artificially boosted by prolonged low interest rates.
Billionaire investor Carl Icahn, who made up with Ackman, tells CNBC Herbalife is not a pyramid scheme and it creates jobs.
I would get back into Apple if I felt more secure abut China, says Carl Icahn, Icahn Enterprises, sharing his thoughts on the tech giant.
Carl Icahn, Icahn Enterprises shares his thoughts on Donald Trump's run for the White House.
Carl Icahn, Icahn Enterprises, discusses how he makes philanthropic decisions, including education and the medical community.
In a wide-ranging conversation, Carl Icahn, Icahn Enterprises, talks to the "Squawk Box" crew about medical philanthropy, George Soros' gold play, market valuations
Carl Icahn, Icahn Enterprises, weighs in on stock valuations.
Billionaire investor Carl Icahn boosted his stake in Hertz Global Holdings to 15.24 percent from 14.34 percent, according to a SEC filing.
Take a look at some of Tuesday's early movers: RL, HTZ, ZG, GDDY, BIIB, VRX & more
Allergan CEO Brent Saunders tells CNBC's "Squawk on the Street" why attention from famed activist investor Carl Icahn's is a stamp of approval.
Ratings firm Moody's believes investors are going to continue to pressure Prudential and AIG into trying to get off the SIFI list as well.
WILMINGTON, Del, May 31- Michael Dell and Silver Lake Partners underpriced their 2013 $24.9 billion buyout of Dell Inc by about 22 percent and may have to pay tens of millions to investors who opposed the deal for the computer maker, a Delaware judge ruled on Tuesday. The lawsuits allow investors who oppose a deal, such as the bitterly contested Dell buyout, to sue and...
Les Funtleyder, Esquared Asset Management, discusses Carl Icahn's large position in Allergan and investing in biotech.
David Maris, Wells Fargo, discusses Carl Icahn's new stake in Allergan.
The activist investor expresses support and confidence in Allergan CEO Brent Saunders.
May 31- Billionaire investor Carl Icahn said on Tuesday he had acquired a "large position" in Botox-maker Allergan Plc and that he was very supportive of Chief Executive Officer Brent Saunders. Saunders had moved into the top spot at Actavis from the CEO job at Forest Labs, which Actavis acquired. Icahn had a Forest Labs stake and was agitating for change when the...
The activist investor also gives a pat on the back for Allergan's CEO.